Approval · Notice of Compliance 29207 · 2022
PROQUAD: Notice of Compliance 29207
Issued October 13, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29207
- Date
- October 13, 2022
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROQUAD | Not yet assigned | — |
Medicinal ingredients
- MEASLES VIRUS VACCINE LIVE ATTENUATED 3 L10T50 per VIAL
- MUMPS VIRUS VACCINE LIVE ATTENUATED JERYL LYNN STRAIN 4.3 L10T50 per VIAL
- RUBELLA VIRUS VACCINE LIVE ATTENUATED WISTAR RA27/3 STRAIN 3 L10T50 per VIAL
- VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED (OKA-STRAIN) 3.99 PFU per VIAL